ESRRA and pulmonary arterial hypertension: In rats and in patients with PAH, maladaptive RV hypertrophy is characterized by a significant reduction in the expression of PGC-1α and its corresponding nuclear receptors PPAR-α, PPAR-γ, and ERR-α [28].